Skip to main content

Articles

Page 4 of 38

  1. Bladder cancer (BLCA) is one of the most common malignancies among tumors worldwide. There are no validated biomarkers to facilitate such treatment diagnosis. DNA methylation modification plays important roles...

    Authors: Hongxia Cheng, Yuhua Liu and Gang Chen
    Citation: BMC Urology 2023 23:135
  2. An arteriovenous fistula is an abnormal communication between an artery and a vein. Traumatic penile arteriospongious fistula is a rare complication and has been described as a cause of erectile dysfunction. C...

    Authors: Polona Vihtelič, Simon Hawlina and Peter Popovič
    Citation: BMC Urology 2023 23:134
  3. The use of postoperative prophylactic antibiotics in pediatric upper urinary tract reconstruction remains controversial. In this study, we examined whether low dose antibiotics administered following pediatric...

    Authors: Kunj Sheth, Kathleen Puttmann, Paige Nichols, Jordon C. King, Huirong Zhu, Sheila Ryan, Andrew T. Gabrielson and Ming-Hsien Wang
    Citation: BMC Urology 2023 23:133
  4. Cystinuria and xanthinuria are both rare genetic diseases involving urinary calculi. However, cases combining these two disorders have not yet been reported.

    Authors: Peide Bai, WenZhao Zhang, Longhui Lai, Haichao Huang, Jiaxuan Qin, Bo Duan, Huiqiang Wang, Yuedong Chen, Yuanyuan Jia, Jinchun Xing, Tao Wang and Bin Chen
    Citation: BMC Urology 2023 23:130
  5. Transplant renal artery aneurysm (TRAA) is rare. TRAA that develops post transplantation consists of 0.10% of the vascular complications post renal transplant (Transplant Proc 41:1609-1614, 2009; Indian J Urol...

    Authors: Collin Elijah Rui Hung Ho, Wei Zheng So, Julian Wong and Ho Yee Tiong
    Citation: BMC Urology 2023 23:129
  6. Management of a bladder tumor during pregnancy is an uncommon clinical situation. Leiomyosarcoma of the urinary bladder is a rare histological type of bladder tumor and a rare secondary cancer in survivors of ...

    Authors: Hayato Hoshina, Satoru Taguchi, Hikaru Suyama, Kenjiro Kishitani, Yoshiyuki Akiyama, Yuta Yamada, Yusuke Sato, Daisuke Yamada, Naoya Akiba, Keiichi Kumasawa, Mayuyo Mori-Uchino, Yutaka Osuga and Haruki Kume
    Citation: BMC Urology 2023 23:125
  7. Radical prostatectomy remains the fundamental treatment for prostate cancer, and improving patients’ compliance with postoperative follow-ups is essential for improving patients’ quality of life. This study in...

    Authors: Jin Ji, Yuchen Yang, Zeyu Chen, Wenhui Zhang, Shaoqin Jiang, Xianqi Shen, Jili Zhang, Lu Lin, Min Qu, Yan Wang and Xu Gao
    Citation: BMC Urology 2023 23:123
  8. Traditional estimates can only provide static predictions of cancer outcomes and cannot assess the evolving effect of race on patient survival. This study aims to reveal the dynamic survival of patients with b...

    Authors: Wei Liu, Jie Xiong, Honghao Wang, Shuo Li, Zhentao Lei, Lili Jiang, Jin Cao, Lin Yang, Hongfeng Guo, Qiang Gao, Shenghan Wang and Bao Zhang
    Citation: BMC Urology 2023 23:122
  9. I kappa B kinase interacting protein, a highly conserved gene, has rarely been reported in cancer. According to previous study, IKBIP has only been shown to promote malignant progression of glioma. In other ma...

    Authors: Huiling Zhang, Rui Tang, Xue Wen, Jingbo Cai, Juan Huang, Li Luo and Zhihui Yang
    Citation: BMC Urology 2023 23:121
  10. This study aimed to explore the value of combined serum lipids with clinical symptoms to diagnose prostate cancer (PCa), and to develop and validate a Nomogram and prediction model to better select patients at...

    Authors: Fu Feng, Yu-Xiang Zhong, Yang Chen, Fu-Xiang Lin, Jian-Hua Huang, Yuan Mai, Peng-Peng Zhao, Wei Wei, Hua-Cai Zhu and Zhan-Ping Xu
    Citation: BMC Urology 2023 23:120
  11. Studies have suggested a positive association between bladder cancer (BC) outcome and comedication use, including nonsteroidal anti-inflammatory drugs (NSAID), metformin, and prednisone use. To validate these ...

    Authors: Michel D. Wissing, Ana O’Flaherty, Alice Dragomir, Simon Tanguay, Wassim Kassouf and Armen G. Aprikian
    Citation: BMC Urology 2023 23:119
  12. Myelolipoma is a benign neoplasm of the adrenal cortex, composed of fat and hematopoietic cells. Although myelolipoma is benign, differentiation from adrenocortical cancer may be difficult. The presence of adr...

    Authors: Hooman Kamran, Abdolreza Haghpanah, Mohammad Hossein Dabbaghmanesh, Lorenzo Defidio, Maryam Bazrafkan, Anahita Dehghani, Mehdi Shirazi, Nima Naderi and Amirreza Dehghanian
    Citation: BMC Urology 2023 23:114
  13. Comparing stone-free rates and associated outcome measures between two surgical modalities of lithotripsy fragmentation and removal or spontaneous passage of dust during retrograde intrarenal surgery (RIRS).

    Authors: Zhi Wen, Li Wang, Yang Liu, Jing Huang, Cai-Xia Chen, Chong-Jian Wang, Lin-Lin Chen and Xue-song Yang
    Citation: BMC Urology 2023 23:113
  14. Nephroureterectomy remains the gold standard treatment for upper tract urothelial carcinoma (UTUC). Considering the high risk of developing renal function impairment after surgery, the rationale for nephron sp...

    Authors: Ahmad Abdelaziz, Mark Sultan, Muhammed A Hammad, Juan Ramon Martinez Jr, Maria Yacoub and Ramy F Youssef
    Citation: BMC Urology 2023 23:111
  15. Traditionally, a pigtail catheter (PCN) is placed for preoperative renal access before performing percutaneous nephrolithotomy (PCNL). However, PCN can hamper the passage of the guidewire to the ureter, due to...

    Authors: Jun-Koo Kang, Sang Hee Lee, Seok-Gi Kim, Ju-Bin Kim, Jeong-Yeon Lee, Seon-Yeon Ha, Chan-Geun Ha, Soon-Ho Hong, Jae-Wook Chung, Yun-Sok Ha, Jun Nyung Lee, So Young Chun and Bum Soo Kim
    Citation: BMC Urology 2023 23:109
  16. Immune checkpoint inhibitors (ICIs) have been approved for the treatment of metastatic renal cell carcinoma (mRCC). However, the response rate is still limited, and it is urgent to pursue novel and concise mar...

    Authors: Soichi Matsumura, Taigo Kato, Yuma Kujime, Hiroaki Kitakaze, Kosuke Nakano, Sachiko Hongo, Iwao Yoshioka, Masayoshi Okumi, Norio Nonomura and Shingo Takada
    Citation: BMC Urology 2023 23:107
  17. As a high-quality TUR-BT is important to ensure adequate treatment for bladder cancer patients, the aim of the current study is to investigate the impact of patient-related, surgical and tumor-specific paramet...

    Authors: Yannic Volz, Rabea Trappmann, Benedikt Ebner, Lennert Eismann, Nikolaos Pyrgidis, Paulo Pfitzinger, Robert Bischoff, Boris Schlenker, Christian Stief and Gerald Bastian Schulz
    Citation: BMC Urology 2023 23:106
  18. To determine the effectiveness of pelvis diameters in determining postoperative outcomes in men who underwent open radical cystectomy + urinary diversion, it is aimed to predict the factors that may affect the...

    Authors: Anil Erdik, Haci Ibrahim Cimen, Osman Kose, Omer Faruk Ates, Onur Taydas, Deniz Gul and Hasan Salih Saglam
    Citation: BMC Urology 2023 23:105
  19. Metabolism is a hallmark of cancer and it involves in resistance to antitumor treatment. Therefore, the purposes of this study are to classify metabolism-related molecular pattern and to explore the molecular ...

    Authors: Bowei Yang, Yongming Jiang, Jun Yang, Wenbo Zhou, Tongxin Yang, Rongchang Zhang, Jinming Xu and Haixiang Guo
    Citation: BMC Urology 2023 23:104
  20. Pure testicular choriocarcinoma is a rare type of non-seminomatous germ cell tumor extremely poor prognostic with the tendency to bleed at the metastatic site. At the time of the diagnosis, 70% of patients hav...

    Authors: Negin Namavari, Lohrasb Taheri, Farhang Hooshmand, Mohammad H. Dousthaghi and Vahid Rahmanian
    Citation: BMC Urology 2023 23:102
  21. As a new pulse modality of holmium laser in retrograde intrarenal stone surgery, the MOSES technique can reduce the possibility of stone drifting and help to powder kidney stones in vitro and in animal experim...

    Authors: Puhan Li, Yucheng Ma, Chi Yuan, Zhongyu Jian and Xin Wei
    Citation: BMC Urology 2023 23:99
  22. Urinary incontinence (UI) is a common worldwide rising health issue among women with a prevalence of 5 to 70%. Stress urinary incontinence (SUI) is the most common subtype of UI. There are different treatments...

    Authors: Pourya Shokri, Ladan Kharaz, Niki Talebian, Nasrin Borumandnia, Seyed Amir Mohsen Ziaee and Nasser Shakhssalim
    Citation: BMC Urology 2023 23:97
  23. To compare the efficacy and safety of standard percutaneous nephrolithotomy (PCNL) with mini- PCNL for kidney stones 2–4 cm.

    Authors: Mohamed Wishahi, Ahmed El Feel, Amr Elkhouly, Abdullah Fahmy, Mamdouh Roshdy, Ahmed G Elbaz, Ahmed I Kamel, Mohamed Badawy, Khaled Elesaily, Samir Eldahshan, Ayman Ali, Ahmed Meheina and Mohamed Abdelwahed
    Citation: BMC Urology 2023 23:96
  24. Scrotal swelling from varicocele is a common complaint in adult men. Varicocele due to portosystemic collaterals is a rare presentation of portal hypertension. Imaging workup and intervention for varicocele in...

    Authors: Ayah Megahed, Todd Schlachter and Joshua Cornman-Homonoff
    Citation: BMC Urology 2023 23:94
  25. Contrast-enhanced ultrasound in percutaneous nephrolithotomy (CEUS-PCNL) is an economical and practical technique for the treatment of patients with renal stones without significant collecting system dilatatio...

    Authors: Li Wang, Kun-peng Li, Shan Yin, Lin Yang and Ping-yu Zhu
    Citation: BMC Urology 2023 23:93
  26. We report the successful management of a paratesticular liposarcoma, which, to the best of our knowledge, is the largest known of its type. A 62-year-old male presented with a painless, gradually progressive l...

    Authors: Cem Aksoy, Philipp Karschuck, Marcus Derigs, Selim Sevinc, Christer Groeben, Aristeidis Zacharis, Luka Flegar, Anika Pehl, Johannes Huber and Subhajit Mandal
    Citation: BMC Urology 2023 23:92
  27. Comparing the long-term tumor control results of partial cystectomy(PC)and radical cystectomy(RC)in the treatment of muscle-invasive bladder cancer, and to explore the feasible method of bladder preservation t...

    Authors: Bin Zhang, Tengfei Liu, Yang He, Dali Han, Peng Qi, Duo Zheng, Junyao Liu, Xingxing Zhang, Zhongjin Yue and Panfeng Shang
    Citation: BMC Urology 2023 23:91
  28. The prognostic value of Hepatocyte growth factor (HGF) in non-clear cell renal cell carcinoma (RCC) is still unclear. The aim of this study is to evaluate the prognostic impact of HGF expression in a large coh...

    Authors: Maximilian Erlmeier, Marie Mikuteit, Stefanie Zschäbitz, Michael Autenrieth, Wilko Weichert, Arndt Hartmann, Sandra Steffens and Franziska Erlmeier
    Citation: BMC Urology 2023 23:90
  29. In intermediate-risk non-muscle invasive bladder cancer (NMIBC) clinical guidelines suggest an adjuvant instillation with a chemotherapeutic agent. However, the agent and regimen are not clearly defined. World...

    Authors: Roland Seiler, Martin Egger, Marta De Menna, Saskia Wehrli, Martina Minoli, Martina Radić, Pavel Lyatoshinsky, Raphael Hösli, Jennifer Blarer, Dominik Abt and Marianna Kruithof-de Julio
    Citation: BMC Urology 2023 23:89
  30. Urothelial carcinoma arises from the inner urothelial membrane of the renal pelvis, ureter, and bladder and often causes macrohematuria. Here, we report a rare case in which the patient developed non-symptomat...

    Authors: Akira Ohtsu, Seiji Arai, Yuji Fujizuka, Reon Fukuda, Keisuke Hori, Yuki Morimura, Rintaro Kawahara, Takuya Shiraishi, Hiroomi Ogawa, Yoshiyuki Miyazawa, Masashi Nomura, Yoshitaka Sekine, Hidekazu Koike, Hiroshi Matsui and Kazuhiro Suzuki
    Citation: BMC Urology 2023 23:88
  31. Lifelong premature ejaculation (LPE) is one of the most common ejaculatory dysfunctions in men. The serotonin (5-HT) synthesis rate-limiting enzyme (TPH2) and receptor (HTR1A) in the 5-HT regulatory system may pl...

    Authors: Fei Wang, Defan Luo, Jianxiang Chen, Cuiqing Pan, Zhongyao Wang, Housheng Fu, Jianbing Xu, Meng Yang, Shaowei Mo, Liying Zhuang and Weifu Wang
    Citation: BMC Urology 2023 23:86

Affiliated with

  • BMC Urology works with with Cochrane Urology in providing our authors with expert advice on systematic reviews and meta-analyses

Annual Journal Metrics

  • 2022 Citation Impact
    2.0 - 2-year Impact Factor
    2.2 - 5-year Impact Factor
    1.177 - SNIP (Source Normalized Impact per Paper)
    0.616 - SJR (SCImago Journal Rank)

    2023 Speed
    39 days submission to first editorial decision for all manuscripts (Median)
    170 days submission to accept (Median)

    2023 Usage 
    1,270,864 downloads
    484 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal